Why Insulet Corp. (PODD) Stock Rose 6.6% on Nov 4, 2026
What happened
Insulet reported third-quarter 2026 earnings and revenues that exceeded analyst estimates, according to Zacks and Business Wire. The stock rallied 4.40% to $161.68 on elevated volume of 2.48x the 80-minute average, signaling strong investor conviction in the beat.
Monitor any conference call commentary on pricing, geographic growth, and competitive positioning in the insulin pump market; track the official earnings release date confirmation and any analyst revisions to full-year 2026 guidance.
Other developments that session
Insulet Corp. (PODD) reported EPS of $1.99 vs. consensus estimate of $1.59, beating by 25.2% on 2026-11-04.
Insulet Corp. (PODD) filed its 10-Q on November 4, 2026. Earnings are scheduled for November 5, 2026, with consensus EPS estimate of $1.59.
Insulet reported Q3 EPS of $1.99, beating estimates by $0.40 and growing 60% year-over-year.
Frequently asked questions
Why did Insulet Corp. (PODD) stock rise on Nov 4, 2026?
Insulet reported third-quarter 2026 earnings and revenues that exceeded analyst estimates, according to Zacks and Business Wire. The stock rallied 4.40% to $161.68 on elevated volume of 2.48x the 80-minute average, signaling strong investor conviction in the beat.
How much did PODD stock rise on Nov 4, 2026?
PODD rose 6.6% during the Nov 4, 2026 trading session.
